Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H35O6.Na |
Molecular Weight | 454.5316 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[H][C@@]12CC[C@H](C(=O)COC(=O)CCC([O-])=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@]4([H])CC(=O)CC[C@]34C
InChI
InChIKey=BFQDICGJHAONBN-OOFWROCWSA-M
InChI=1S/C25H36O6.Na/c1-24-11-9-16(26)13-15(24)3-4-17-18-5-6-20(25(18,2)12-10-19(17)24)21(27)14-31-23(30)8-7-22(28)29;/h15,17-20H,3-14H2,1-2H3,(H,28,29);/q;+1/p-1/t15-,17+,18+,19+,20-,24+,25+;/m1./s1
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13356183 |
Preventing | Viadril Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Steroid anesthetic agent. | 1955 Jul 8 |
|
Viadril: a new steroid anaesthetic; preliminary communication. | 1956 Jul 21 |
|
Hydroxydione sodium (viadril) for anesthesia; a report of clinical experience. | 1956 Sep |
|
Studies on the clinical and pathological effects of hydroxydione. | 1961 Oct |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
23689389
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
DBSALT001079
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
53J8I8O5EW
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
53-10-1
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110850
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
DTXSID20967464
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
C75960
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
100000083640
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
714
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | |||
|
m1188
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB08078MIG
Created by
admin on Fri Dec 15 15:11:34 GMT 2023 , Edited by admin on Fri Dec 15 15:11:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD